Mkts

Utah Medical Products, Inc.

NASDAQ: UTMD
$72.42-1.21 (-1.64%)
As of Nov 13, 2:55 PM ET

Key statistics

Day range
72.1873.32
52-week range
53.6676.89
Today
Open73.31
Previous close72.42
Volume19.6K
Valuation
Market cap224.80M
P/E ratio21.44×
EPS (TTM)3.28
Income & risk
Dividend / yield1.22 / 1.45%
Beta0.44
Avg volume34.9K
Discussion

UTMD News

Stories mentioning UTMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue8,7229,0449,8129,9539,7109,15710,00510,400
Cost of Goods Sold3,4403,7814,2084,3584,1723,8364,2034,147
Gross Profit5,2825,2645,6045,5955,5385,3235,8026,253
Operating Expenses
Research & Development154.00212.00167.00135.00154.00120.00172.00255.00
Sales General & Admin2,5632,8262,2642,2312,2872,560
Total Operating Expenses2,7172,9932,3992,3852,4592,815
Operating Income (Loss)2,5652,4422,6113,1963,1532,9303,3433,438
Interest Income
Interest Expense
Other Expense617.00(2,163)698.00640.00705.00(2,698)836.00773.00
Pretax Income3,1823,1073,3093,8363,8583,6144,1794,211
Tax Provision578.00541.00678.00788.00817.00712.00616.00758.00
Net Income (Loss)
Earnings Per Share (Basic)0.820.000.820.940.920.001.020.98
Earnings Per Share (Diluted)0.820.800.820.940.920.861.030.98
Weighted Average Shares Outstanding (Basic)3,1853,2403,2073,2463,3103,5033,4783,532
Weighted Average Shares Outstanding (Diluted)3,1853,2403,2073,2463,3103,5033,4783,532

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About UTMD

Utah Medical Products, Inc. (NASDAQ: UTMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol UTMD. It last traded at $72.42 (Nov 13, 2026, 2:55 PM ET), down 1.6% on the day. That gives Utah Medical Products a market capitalisation of $224.8M and a price-to-earnings ratio of 21.4.

Over the past 52 weeks UTMD has traded between $53.66 and $76.89.

Revenue for the quarter ended Mar 31, 2026 was $8.7M. Revenue was down 10.2% from $9.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$8.7M—
Dec 31, 2025$9.0M—
Sep 30, 2025$9.8M—
Jun 30, 2025$10.0M—

From Utah Medical Products’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…